| 461 | NEWMAN, LISA A.PHILADELPHIA, PA · 19112 | MANAGER, SPECIALTY ACCESS & REIMBURSEM · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 462 | PARKS, KEVIN R.ZEBULON, NC · 27597 | SITE ENGINEERING LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 463 | GUEDRY, KELLY PDURHAM, NC · 27709 | RX ACCOUNT MGMT RETAIL EXECUTIVE (SALE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 464 | STEFL, JOHNDURHAM, NC · 27709 | CIGNA ENTERPRISE MARKET ANALYTICS DIRE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 465 | BARONE, JESSICADURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 466 | CHACON, JAVIER F.DURHAM, NC · 27709 | SR. ACCT SPEC, VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 467 | GROSSMANN, GLENN RUSSELLDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 468 | ADAMS, GRACE E.DURHAM, NC · 27709 | SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 469 | BROOKERD, DONNA RDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 470 | VIGGIANO, DOROTHY P.DURHAM, NC · 27709 | SR SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 471 | DHAR, ARINDAMCOLLEGEVILLE, PA · 19426 | EXECUTIVE MEDICAL DIRECTOR, CLINICAL D · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $9 | Primary (P) | Filing 1928923FEC filing ↗ |
| 472 | SCOTT, BRENDA MESLEYDURHAM, NC · 27709 | SR. ACCT SPEC, VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $9 | Primary (P) | Filing 1928923FEC filing ↗ |
| 473 | GUNN, LYNETTE R.DURHAM, NC · 27709 | RX SALES PRIMARY CARE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $9 | Primary (P) | Filing 1928923FEC filing ↗ |
| 474 | PELLOQUIN, MARK J.DURHAM, NC · 27709 | VACCINES STRATEGIC ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-21 | $9 | Primary (P) | Filing 1928923FEC filing ↗ |
| 475 | SCOTT, BRENDA MESLEYDURHAM, NC · 27709 | SR. ACCT SPEC, VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-06 | $9 | Primary (P) | Filing 1928923FEC filing ↗ |
| 476 | PELLOQUIN, MARK J.DURHAM, NC · 27709 | VACCINES STRATEGIC ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-11-06 | $9 | Primary (P) | Filing 1928923FEC filing ↗ |
| 477 | CORPENING, BELMASAINT LOUIS, MO · 63128 | MEDICAL SCIENCE LIAISON · GSK | TALARICO FOR TEXASC00919084 | 2025-10-18 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 2011129 · amendedFEC filing ↗ |
| 478 | SAMATIS, CHRISTIANSTONEHAM, MA · 02180 | LOGISTICS DIRECTOR · GSK | TALARICO FOR TEXASC00919084 | 2025-10-07 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 2011129 · amendedFEC filing ↗ |
| 479 | CORPENING, BELMASAINT LOUIS, MO · 63128 | MEDICAL SCIENCE LIAISON · GSK | TALARICO FOR TEXASC00919084 | 2025-12-18 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 2011129 · amendedFEC filing ↗ |
| 480 | CORPENING, BELMASAINT LOUIS, MO · 63128 | MEDICAL SCIENCE LIAISON · GSK | TALARICO FOR TEXASC00919084 | 2025-11-18 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 2011129 · amendedFEC filing ↗ |